National Health Investors, Inc. (NYSE:NHI) released its quarterly earnings results on Wednesday. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.29 by $0.36, MarketWatch Earnings reports. National Health Investors had a net margin of 63.72% and a return on equity of 13.36%. The company had revenue of $69.84 million for the quarter, compared to the consensus estimate of $67.68 million. During the same period in the prior year, the firm posted $1.22 EPS. The business’s revenue for the quarter was up 14.1% on a year-over-year basis. National Health Investors updated its FY17 guidance to $5.22-5.26 EPS.

National Health Investors (NYSE NHI) traded up 0.75% during trading on Thursday, hitting $76.63. The stock had a trading volume of 13,137 shares. National Health Investors has a 52-week low of $66.31 and a 52-week high of $82.53. The company has a market cap of $3.14 billion, a price-to-earnings ratio of 18.61 and a beta of 0.56. The firm’s 50-day moving average price is $77.50 and its 200-day moving average price is $75.01.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 10th. Stockholders of record on Friday, September 29th will be paid a $0.95 dividend. This represents a $3.80 dividend on an annualized basis and a dividend yield of 5.00%. The ex-dividend date is Thursday, September 28th. National Health Investors’s dividend payout ratio (DPR) is 92.23%.

Several analysts have issued reports on the company. BidaskClub lowered National Health Investors from a “hold” rating to a “sell” rating in a report on Wednesday. Bank of America Corporation lowered National Health Investors from a “neutral” rating to an “underperform” rating and set a $76.00 price target for the company. in a report on Monday, May 22nd. ValuEngine lowered National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, June 13th. Zacks Investment Research raised National Health Investors from a “hold” rating to a “buy” rating and set a $81.00 price target for the company in a report on Wednesday, May 10th. Finally, Stifel Nicolaus boosted their price target on National Health Investors from $80.00 to $82.00 and gave the company a “buy” rating in a report on Wednesday, June 21st. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $79.60.

TRADEMARK VIOLATION NOTICE: “National Health Investors, Inc. (NHI) Announces Quarterly Earnings Results” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another domain, it was copied illegally and republished in violation of United States & international copyright legislation. The original version of this news story can be viewed at

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Earnings History for National Health Investors (NYSE:NHI)

Receive News & Stock Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related stocks with our FREE daily email newsletter.